Systematic review: The combined surgical and medical treatment of fistulising perianal Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 7, 2014, Pages 741-749

  Yassin, N A ^a,b   Askari, A ^a,b   Warusavitarne, J ^a,b   Faiz, O D ^a,b   Athanasiou, T ^b,c   Phillips, R K S ^a,b   Hart, A L ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; IMMUNOLOGIC FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANUS FISTULA; CROHN DISEASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATIENT SELECTION; PRACTICE GUIDELINE; RADIOGRAPHY; REMISSION; REVIEW; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VERY ELDERLY; ANTAGONISTS AND INHIBITORS; MULTIMODALITY CANCER THERAPY; RECTAL FISTULA; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; CROHN DISEASE; HUMANS; IMMUNOLOGIC FACTORS; RECTAL FISTULA; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908142512     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12906     Document Type: Review

References (53)

1. Lapidus A, Bernell O, Hellers G, Löfberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151-60.
2. Schwartz DA, Loftus EV, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-80.
3. Schwartz DA, Maltz BE. Treatment of fistulizing inflammatory bowel disease. Med Clin North Am 2010; 94: 19-34.
4. Bressler B, Sands BE. Review article: Medical therapy for fistulizing Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1283-93.
5. Schwartz DA, Herdman CR. Review article: The medical treatment of Crohn's perianal fistulas. Aliment Pharmacol Ther 2004; 19: 953-67.
6. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebocontrolled pilot study. Inflamm Bowel Dis 2009; 15: 17-24.
7. West RL, van der Woude CJ, Hansen BE, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20: 1329-36.
8. Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1113-20.
9. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132-42.
10. Ingle SB, Loftus EV. The natural history of perianal Crohn's disease. Dig Liver Dis 2007; 39: 963-9.
11. Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21: 525-7.
12. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-405.
13. Tozer P, Ng SC, Siddiqui MR, et al. Long-term MRI-guided combined anti-TNF-a and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 2012; 18: 1825-34.
14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-34.
15. Wells G, Shea B, O'Connell D, Robertson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2011; http://www.ohri.ca/ programs /clinicalepidemiology/oxford.asp.
16. El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas. Colorectal Dis 2012; 14: 1217-23.
17. Bouguen G, Siproudhis L, Gizard E, et al. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11: 975-81.e1-4.
18. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 2002; 45: 771-5.
19. Farrell RJ, Shah SA, Lodhavia PJ, et al. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am J Gastroenterol 2000; 95: 3490-7.
20. Mizrahi N, Wexner SD, Zmora O, et al. Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 2002; 45: 1616-21.
21. Pearl RK, Andrews JR, Orsay CP, et al. Role of the seton in the management of anorectal fistulas. Dis Colon Rectum. 1993; 36: 573-7; discussion 577-9.
22. Williams JG, MacLeod CA, Rothenberger DA, Goldberg SM. Seton treatment of high anal fistulae. Br J Surg 1991; 78: 1159-61.
23. Ellis CN. Sphincter-preserving fistula management: what patients want. Dis Colon Rectum 2010; 53: 1652-5.
24. Lunniss PJ, Kamm MA, Phillips RK. Factors affecting continence after surgery for anal fistula. Br J Surg 1994; 81: 1382-5.
25. Roig JV, Jordán J, García-Armengol J, Esclapez P, Solana A. Changes in anorectal morphologic and functional parameters after fistula-in-ano surgery. Dis Colon Rectum 2009; 52: 1462-9.
26. Yassin NA, Hammond TM, Lunniss PJ, Phillips RKS. Ligation of the intersphincteric fistula tract in the management of anal fistula. A systematic review. Colorectal Dis 2013; 15: 527-35.
27. Schwandner O. Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn's disease. Tech Coloproctol 2013; 17: 221-5.
28. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48: 1416-23.
29. Lewis RT, Bleier JIS. Surgical treatment of anorectal crohn disease. Clin Colon Rectal Surg 2013; 26: 90-9.
30. García-Aguilar J, Davey CS, Le CT, Lowry AC, Rothenberger DA. Patient satisfaction after surgical treatment for fistula-in-ano. Dis Colon Rectum 2000; 43: 1206-12.
31. Riss S, Schwameis K, Mittlböck M, et al. Sexual function and quality of life after surgical treatment for anal fistulas in Crohn's disease. Tech Coloproctol 2013; 17: 89-94.
32. Ng SC, Plamondon S, Gupta A, Burling D, Kamm MA. Prospective assessment of the effect on quality of life of antitumour necrosis factor therapy for perineal Crohn's fistulas. Aliment Pharmacol Ther 2009; 30: 757-66.
33. Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 2010; 53: 299-304.
34. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003; 9: 98-103.
35. Topstad DR, Panaccione R, Heine JA, Johnson DRE, MacLean AR, Buie WD. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003; 46: 577-83.
36. Van der Hagen SJ, Baeten CG, Soeters PB, Russel MGVM, Beets-Tan RG, van Gemert WG. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. Dis Colon Rectum 2005; 48: 758-67.
37. Schwartz DA, White CM, Wise PE, Herline AJ. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Inflamm Bowel Dis 2005; 11: 727-32.
38. Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D. Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis 2005; 7: 164-8.
39. Hyder SA, Travis SPL, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-41.
40. Gaertner WB, Decanini A, Mellgren A, et al. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50: 1754-60.
41. Spradlin NM, Wise PE, Herline AJ, Muldoon RL, Rosen M, Schwartz DA. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Am J Gastroenterol 2008; 103: 2527-35.
42. Guidi L, Ratto C, Semeraro S, et al. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience. Tech Coloproctol 2008; 12: 111-7.
43. Kraemer M, Kirschmeier A, Marth T. Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease. Int J Colorectal Dis 2008; 23: 965-9.
44. Higashi D, Futami K, Egawa Y, et al. Infliximab treatment for anal fistula in patients with Crohn's disease. Anticancer Res 2009; 29: 927-33.
45. Tougeron D, Savoye G, Savoye-Collet C, Koning E, Michot F, Lerebours E. Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. Dig Dis Sci 2009; 54: 1746-52.
46. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52: 79-86.
47. Tanaka S, Matsuo K, Sasaki T, Beppu R, Yamashita Y, Maeda K, Aoyagi K. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Hepatogastroenterology. 2010; 57: 3-7.
48. Gligorijević V, Spasić N, Bojić D, et al. The role of pelvic MRI in assesment of combined surgical and infliximab treatment for perianal Crohn's disease. Acta Chir Iugosl 2010; 57: 89-95.
49. Hotokezaka M, Ikeda T, Uchiyama S, Tsuchiya K, Chijiiwa K. Results of seton drainage and infliximab infusion for complex anal Crohn's disease. Hepatogastroenterology. 2011; 58: 1189-92.
50. Gaertner WB, Madoff RD, Spencer MP, Mellgren A, Goldberg SM, Lowry AC. Results of combined medical and surgical treatment of recto-vaginal fistula in Crohn's disease. Colorectal Dis 2011; 13: 678-83.
51. Uchino M, Ikeuchi H, Bando T, et al. Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease. World J Gastroenterol 2011; 17: 1174-9.
52. Roumeguére P, Bouchard D, Pigot F, et al. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study. Inflamm Bowel Dis 2011; 17: 69-76.
53. Antakia R, Shorthouse AJ, Robinson K, Lobo AJ. Combined modality treatment for complex fistulating perianal Crohn's disease. Colorectal Dis 2013; 15: 210-6.